Patents by Inventor Aviad MANDABI

Aviad MANDABI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230212131
    Abstract: The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: June 9, 2021
    Publication date: July 6, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Wolfgang SCHMIDT, Stefano LEVANTO, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Yaode WANG, Haitang LI
  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230150980
    Abstract: The present invention relates to novel Collagen I translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: April 21, 2021
    Publication date: May 18, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Wolfgang SCHMIDT, Stefano LEVANTO, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Yaode WANG, Haitang Ll, Stephen David PENROSE
  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230116201
    Abstract: The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: January 28, 2021
    Publication date: April 13, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Wolfgang SCHMIDT, William Rameshchandra ESMIEU, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Aviad MANDABI
  • C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
    Publication number: 20220370431
    Abstract: The present invention relates to novel c-MYC mRNA translation modulators, composition and methods of preparation thereof, and uses thereof in the treatment of cancer.
    Type: Application
    Filed: July 3, 2022
    Publication date: November 24, 2022
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Iris ALROY, Rina WASSERMANN, Yaode WANG, Haitang LI, Yoni SHEINBERGER
  • PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PYROXASULFONE
    Publication number: 20220267279
    Abstract: The invention provides a process which comprises the step of thiomethylating a pyrazole, to create R2—C(O)—S—CH2— functionality at position 4 of the pyrazole ring. The process is useful in preparing Pyroxasulfone. The invention also provides intermediates.
    Type: Application
    Filed: July 29, 2020
    Publication date: August 25, 2022
    Inventors: Yaniv BARDA, Aviad MANDABI, Carl RECSEI